Stock LINCOLN LINCOLN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Lincoln Pharmaceuticals Limited

Equities

LINCOLN

INE405C01035

Market Closed - Bombay S.E.
Other stock markets
 11:00:48 10/05/2024 BST 		5-day change 1st Jan Change
569.2 INR +3.13% Intraday chart for Lincoln Pharmaceuticals Limited -4.55% -6.56%
03-30 Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director CI
02-22 Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director
CI
Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director
CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Lincoln Pharmaceuticals Limited Declares Dividend for the Financial Year 2022-23
CI
Lincoln Pharmaceuticals Limited Proposes Dividend for the Financial Year 2022-2023
CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023
CI
Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company
CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Lincoln Pharmaceuticals Limited Informs About Demise of Shri Ishwarlal Ambalal Patel Independent Director
CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Lincoln Pharmaceuticals Limited Appoints Trusha Shah as Company Secretary and Compliance Officer
CI
Lincoln Pharmaceuticals Limited Approves to Declare Dividend for the Financial Year 2021-22
CI
Lincoln Pharmaceuticals Limited Proposes to Declare Dividend for the Financial Year 2021-2022
CI
Lincoln Pharmaceuticals Limited Approves Appointment of Anand A. Patel as an Additional and Whole Time Director
CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Lincoln Pharmaceuticals Limited Announces Resignation of Niren A. Desai as Company Secretary / Compliance Officer, with Effect from July 19, 2022
CI
Lincoln Pharmaceuticals : Newspaper Advertisements
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LINCOLN Stock
  4. News Lincoln Pharmaceuticals Limited